远程医疗干预对中风后认知障碍认知功能的影响:系统性审查和元分析
Qiqing Zhong1, Yifan Wu1, Shengze Zhi1
1School of Nursing, Jilin University, Changchun, People's Republic of China.
Journal of telemedicine and telecare
|July 15, 2025
概括
远程医疗有效地改善了中风后患者的认知功能和日常生活活动. 这种方法比传统的康复方法具有显著的优势.
科学领域:
- 神经科学是一个神经科学.
- 康复医学 康复医学 康复医学
- 医疗信息学 医疗信息学
背景情况:
- 脑卒中后认知障碍 (PSCI) 影响个人在中风后六个月内.
- 远程医疗,利用远程通信技术,已经证明了在管理认知缺陷方面的潜力.
- 此前还没有针对远程医疗对PSCI结果的影响进行具体的系统审查.
研究的目的:
- 系统地审查和评估远程医疗干预对中风后认知障碍患者认知功能的有效性.
主要方法:
- 在10个主要的电子数据库中进行了全面的系统文献搜索,截至2025年5月.
- 包含的研究是按照系统审查和元分析 (PRISMA) 准则的首选报告项目进行分析的.
- 使用Review Manager 5.3和Stata 15进行了元分析,以综合来自19项选定的研究的发现.
主要成果:
- 远程医疗干预对全球认知有显著的中度影响 (SMD = 0.69,P < 0.01).
- 在视觉空间功能 (SMD = 0.57,P < 0.05) 和语言 (SMD = 0.62,P < 0.05) 中观察到显著改善.
- 远程医疗也对日常生活活动产生了积极的影响 (SMD = 0.64,P < 0.01),对在线工具和移动应用程序都注意到了影响.
结论:
- 远程医疗为管理中风后认知障碍提供了一个有效的策略,提供了显著的认知改善.
- 它作为传统面对面康复的可行替代方案,克服了可访问性的限制.
- 未来的研究应该专注于减少异质性,结合长期跟踪,神经成像和生物标志物,以了解潜在的机制.
更多相关视频
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
613
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
3.1K
相关概念视频
Cognitive Development During Adulthood
289
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
289
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
212
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
212
